The Immunomodulating Role of B-cells in IgA Nephropathy – Focus on APRIL
This session will provide a comprehensive overview of the immunomodulating role of B cells in IgAN, from basic biology to clinical implications.
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Webinar
From Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss some of the challenges in her own practice.
Transition of Care from Pediatric to Adult Nephrology Webinar
During this webinar, Dr. McCune and Dr. Greco will discuss the process of transitioning from pediatric to adult nephrology care.
A Targeted Approach for Immunoglobulin-A Nephropathy
Dr. Srinivasan will discuss the four hit pathogenic process of IgA nephropathy, including the role of galactose deficient immunoglobulin-A1 (Gd-IgA1) and A-proliferation inducing ligand (APRIL).
Navigating the Differential Diagnosis of Proteinuria with an Emphasis on IgA Nephropathy
This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and what the unmet need is.
KDIGO Clinical Practice Guideline for the Evaluation, Management, & Treatment of ADPKD (Part 1)
The goal of this webinar series is to review the 2025 KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of ADPKD.
KDIGO Clinical Practice Guideline for the Evaluation, Management, & Treatment of ADPKD (Part 2)
The goal of this webinar series is to review the 2025 KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of ADPKD.
KDIGO Clinical Practice Guideline for the Evaluation, Management, & Treatment of ADPKD (Part 3)
The goal of this webinar series is to review the 2025 KDIGO Clinical Practice Guideline for the Evaluation, Management, and Treatment of ADPKD.
Biomarkers in IgA Nephropathy
This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and what the unmet need is.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
